NLRP1 and cancer: Additionally, the analysis of DFS data demonstrated that decreased NLRP1 transcription levels correlated with poor prognosis in various cancers, including CHOL (p = 0.039, HR = 0.37), LUAD (p = 0.033, HR = 0.72), and PAAD (p = 0.00037, HR = 0.45).